We are live on
!
Find out more
NP
Newlight Partners Portfolio holdings
AUM
$3.9M
1-Year Est. Return
96.05%
This Fund
S&P 500
This Quarter
Est. Return
-17.48%
1 Year Est. Return
-96.05%
3 Year Est. Return
-92.84%
5 Year Est. Return
-96.09%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
-$333M
(-18%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Biosciences
HRMY
|
+$10.2M |
| 2 |
Blue Owl Capital
OWL
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.9% |
| 2 | Financials | 13.88% |
| 3 | Technology | 10.16% |
| 4 | Consumer Staples | 0.05% |
Similar funds
BPWM
TCP
CP
CCM
HIP
AI
CAWM
ADIM
Newlight Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Newlight Partners held 5 positions worth $1.48B, down 18% from $1.81B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 0%. Newlight Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 76% a quarter earlier, followed by Financials and Technology.
- Newlight Partners's biggest Q1 2022 reduction was Harmony Biosciences, cutting an estimated $10.2M.
- Newlight Partners's ten largest holdings make up 100% of its $1.48B portfolio in Q1 2022.
- Newlight Partners opened 0 new positions and closed 0 in Q1 2022.
- Newlight Partners's portfolio value fell 18% quarter-over-quarter to $1.48B.
Based on Newlight Partners's 13F filing for Q1 2022, filed 12 May 2022.